BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 30582658)

  • 21. Diagnostic tools in the differential diagnosis of giant cell-rich lesions of bone at biopsy.
    Rehkämper J; Steinestel K; Jeiler B; Elges S; Hekeler E; Huss S; Sperveslage J; Hardes J; Streitbürger A; Gosheger G; Wardelmann E; Baumhoer D; Trautmann M; Hartmann W
    Oncotarget; 2018 Jul; 9(53):30106-30114. PubMed ID: 30046391
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Profiling of potential driver mutations in sarcomas by targeted next generation sequencing.
    Andersson C; Fagman H; Hansson M; Enlund F
    Cancer Genet; 2016 Apr; 209(4):154-60. PubMed ID: 26987750
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Highly recurrent H3F3A mutations with additional epigenetic regulator alterations in giant cell tumor of bone.
    Ogura K; Hosoda F; Nakamura H; Hama N; Totoki Y; Yoshida A; Ohashi S; Rokutan H; Takai E; Yachida S; Kawai A; Tanaka S; Shibata T
    Genes Chromosomes Cancer; 2017 Oct; 56(10):711-718. PubMed ID: 28545165
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeted RNA sequencing: A routine ancillary technique in the diagnosis of bone and soft tissue neoplasms.
    Dickson BC; Swanson D
    Genes Chromosomes Cancer; 2019 Feb; 58(2):75-87. PubMed ID: 30350361
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic value of H3F3A mutations in giant cell tumour of bone compared to osteoclast-rich mimics.
    Presneau N; Baumhoer D; Behjati S; Pillay N; Tarpey P; Campbell PJ; Jundt G; Hamoudi R; Wedge DC; Loo PV; Hassan AB; Khatri B; Ye H; Tirabosco R; Amary MF; Flanagan AM
    J Pathol Clin Res; 2015 Apr; 1(2):113-23. PubMed ID: 27499898
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinicopathologic characterization of malignant chondroblastoma: a neoplasm with locally aggressive behavior and metastatic potential that closely mimics chondroblastoma-like osteosarcoma.
    Papke DJ; Hung YP; Schaefer IM; Bredella MA; Charville GW; Reith JD; Fletcher CDM; Nielsen GP; Hornick JL
    Mod Pathol; 2020 Nov; 33(11):2295-2306. PubMed ID: 32601382
    [TBL] [Abstract][Full Text] [Related]  

  • 27. H3.3 K36M Mutation as a Clinical Diagnosis Method of Suspected Chondroblastoma Cases.
    Mu H; Jiang Y; Xue L; Hua Y; Lin J; Cai Z
    Orthop Surg; 2021 Apr; 13(2):616-622. PubMed ID: 33620145
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of a novel, recurrent HEY1-NCOA2 fusion in mesenchymal chondrosarcoma based on a genome-wide screen of exon-level expression data.
    Wang L; Motoi T; Khanin R; Olshen A; Mertens F; Bridge J; Dal Cin P; Antonescu CR; Singer S; Hameed M; Bovee JV; Hogendoorn PC; Socci N; Ladanyi M
    Genes Chromosomes Cancer; 2012 Feb; 51(2):127-39. PubMed ID: 22034177
    [TBL] [Abstract][Full Text] [Related]  

  • 29. USP6 and CDH11 oncogenes identify the neoplastic cell in primary aneurysmal bone cysts and are absent in so-called secondary aneurysmal bone cysts.
    Oliveira AM; Perez-Atayde AR; Inwards CY; Medeiros F; Derr V; Hsi BL; Gebhardt MC; Rosenberg AE; Fletcher JA
    Am J Pathol; 2004 Nov; 165(5):1773-80. PubMed ID: 15509545
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeted next-generation sequencing of CIC-DUX4 soft tissue sarcomas demonstrates low mutational burden and recurrent chromosome 1p loss.
    Lazo de la Vega L; Hovelson DH; Cani AK; Liu CJ; McHugh JB; Lucas DR; Thomas DG; Patel RM; Tomlins SA
    Hum Pathol; 2016 Dec; 58():161-170. PubMed ID: 27664537
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synovial chondromatosis and soft tissue chondroma: extraosseous cartilaginous tumor defined by FN1 gene rearrangement.
    Amary F; Perez-Casanova L; Ye H; Cottone L; Strobl AC; Cool P; Miranda E; Berisha F; Aston W; Rocha M; O'Donnell P; Pillay N; Tirabosco R; Baumhoer D; Hookway ES; Flanagan AM
    Mod Pathol; 2019 Dec; 32(12):1762-1771. PubMed ID: 31273315
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Smooth muscle actin expression in primary bone tumours.
    Hemingway F; Kashima TG; Mahendra G; Dhongre A; Hogendoorn PC; Mertens F; Athanasou NA
    Virchows Arch; 2012 May; 460(5):525-34. PubMed ID: 22543453
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Benign and malignant giant-cell rich lesions of bone: Pathological diagnosis with special emphasis on recent immunohistochemistry and molecular techniques].
    Macagno N; Caselles K; Aubert S; Audard V; Gomez-Brouchet A; Galant C; Guinebretière JM; Karanian M; Larousserie F; Marie B; de Pinieux G; Bouvier C
    Ann Pathol; 2018 Apr; 38(2):92-102. PubMed ID: 29580573
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular pathology and its diagnostic use in bone tumors.
    Szuhai K; Cleton-Jansen AM; Hogendoorn PC; Bovée JV
    Cancer Genet; 2012 May; 205(5):193-204. PubMed ID: 22682618
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Histones and their practical application in bone tumors: Do I always need them?
    Reith JD
    Hum Pathol; 2024 May; 147():92-100. PubMed ID: 38307341
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pathogenic and Targetable Genetic Alterations in Resected Recurrent Undifferentiated Pleomorphic Sarcomas Identified by Targeted Next-generation Sequencing.
    Zheng B; Qu Y; Wang J; Shi Y; Yan W
    Cancer Genomics Proteomics; 2019; 16(3):221-228. PubMed ID: 31018952
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of Next-Generation Sequencing as a Diagnostic Tool for the Evaluation of Bone and Soft-Tissue Tumors.
    Szurian K; Kashofer K; Liegl-Atzwanger B
    Pathobiology; 2017; 84(6):323-338. PubMed ID: 28817827
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular profiling of osteosarcoma in children and adolescents from different age groups using a next-generation sequencing panel.
    Guimarães GM; Tesser-Gamba F; Petrilli AS; Donato-Macedo CRP; Alves MTS; de Lima FT; Garcia-Filho RJ; Oliveira R; Toledo SRC
    Cancer Genet; 2021 Nov; 258-259():85-92. PubMed ID: 34666222
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MR imaging of primary bone tumors and tumor-like conditions in children.
    Wootton-Gorges SL
    Magn Reson Imaging Clin N Am; 2009 Aug; 17(3):469-87, vi. PubMed ID: 19524197
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IDH1 mutations are not found in cartilaginous tumours other than central and periosteal chondrosarcomas and enchondromas.
    Damato S; Alorjani M; Bonar F; McCarthy SW; Cannon SR; O'Donnell P; Tirabosco R; Amary MF; Flanagan AM
    Histopathology; 2012 Jan; 60(2):363-5. PubMed ID: 22074484
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.